Stages:

• Early

 

Industries:

Life Sciences & Healthcare

Medical Device

 

Description:

Broadview Ventures, Inc. is associated with the Paris based Foundation Leducq. In 2008, the trust of the Leducq Foundation created a new company, Broadview Ventures, to accelerate the translation of scientific discoveries into clinical benefit in cardiovascular and neurovascular disease through targeted investment in support of early stage technology. Although associated with the Leducq Foundation, with which it shares an overlap of mission and philosophy, BV is constituted as an independent, for-profit venture philanthropy corporation. Profits from this company must be used for further targeted investment through Broadview Ventures, or for Leducq Foundation grant funding. Broadview Ventures is designed to help overcome the problem of the so called 'translation gap,' where very early stage companies find that their research is too advanced for traditional academic funding, but not sufficiently developed to attract conventional venture capital investment. As of 2009, Broadview Ventures had invested in percutaneous valve replacement and micro-RNA technology. Since 2009, Broadview has advanced its mission by investing in 44 companies.